title: Genomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patients.
abstract: BACKGROUND
  Exploration of genetic changes during active Schistosoma infection is important for anticipation and prevention of chronic sequelae. This study aimed to explore the genomic instability in chromosomal and cellular kinetics in Egyptians suffering from uncomplicated active schistosomiasis haematobium infection in addition to chronic schistosomiasis haematobium cases complicated by bilharzial-associated bladder cancer (BAC).
  
  
  RESULTS
  This study was conducted on 46 schistosomiasis haemotobium cases, 22 were active (Viable S. haematobium eggs in urine samples as detected by microscopy) and 24 were chronic complicated with bladder cancer. Three cytogenetic techniques were applied; the first was quantitative nuclear-morphocytometry by means of which the Feulgen-stained nuclei were analyzed for parameters including shape, size, integrated optical-density and nuclear area. The second was Fluorescent In-Situ Hybridization (FISH) for specific p53gene-locus of chromosome 17 and the third technique was karyotyping. Concerning chronic complicated cases, the mean ± SD of DNA-content in urinary bladder tissue sections was 3.18 ± 0.65. Five samples (20.83%) of bladder tissue sections of chronic complicated cases showed diploid nuclei, 6 urinary bladder tissue samples (25%) were tetraploid, while 13 bladder samples (54.16%) were aneuploid. Epithelial cells of urine samples demonstrated aneuploidy (mean ± SD = 3.74 ± 0.36).Nuclear contents showed high proliferative DNA index in all urinary epithelial cells. In the acute uncomplicated group, nuclear-DNA of urinary epithelial cells was found diploid with mean nuclear-DNA content of 2.2 ± 0.16SD. Half of these diploid smears had a high proliferation index. The difference between nuclear DNA-contents in acute and chronic cases was significant (P = 0.0001). FISH technique for specific p53gene-locus and karyotyping were done on urinary bladder tissue specimens and peripheral blood monocytes of 8 chronic cases respectively. Three samples (37.5%) with invasive BAC had a deletion of the p53 gene. Karyotyping showed three cases out of the 8 chronic schistosomiasis haematobium patients with chromosomal fragmentations.
  
  
  CONCLUSIONS
  DNA morphometry was valuable in detection of gross genetic changes in urothelial tissues. It is an important prognostic factor in established schistosomiasis haematobium induced bladder malignancy. It has the great advantage of being applicable on urine cells making it suitable for the prediction of a tendency towards genetic instability in active schistosomiasis haematobium patients.
authors: Parasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors: Amany A
authors: AA
authors: Abd El-Aal
authors: Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
authors: Ibrahim R
authors: IR
authors: Bayoumy
authors: Parasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors: Maha M A
authors: MM
authors: Basyoni
authors: Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors: Asmaa A
authors: AA
authors: Abd El-Aal
authors: Urosurgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors: Ashraf M
authors: AM
authors: Emran
authors: Parasitology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
authors: Magda S
authors: MS
authors: Abd El-Tawab
authors: Pathology Department, National Research Center, Giza, Egypt.
authors: Manal A
authors: MA
authors: Badawi
authors: Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
authors: Rabab M
authors: RM
authors: Zalat
authors: Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt.
authors: Tarek M
authors: TM
authors: Diab
keywords: Chromosomal abnormalities; FISH; Karyotyping; Morphocytometry; Schistosomiasis haematobium
references: Infect Agent Cancer. 2013 May 24;8(1):19
references: 23705833
references: Clin Cancer Res. 1997 Apr;3(4):531-6
references: 9815716
references: Cancer Res. 1994 Feb 1;54(3):784-8
references: 8306342
references: Cancer Res. 2002 Feb 1;62(3):809-18
references: 11830537
references: Clin Microbiol Rev. 1999 Jan;12(1):97-111
references: 9880476
references: Mol Biol Rep. 2011 Aug;38(6):4101-9
references: 21107709
references: Anticancer Res. 2011 Jan;31(1):53-8
references: 21273580
references: Int J Cancer. 1994 Feb 1;56(3):347-53
references: 7906253
references: Parasitology. 2009 Oct;136(12):1593-610
references: 19627633
references: Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):979-83
references: 17507625
references: Mol Carcinog. 1994 Jan;9(1):33-9
references: 8297483
references: Mol Cytogenet. 2010 Oct 19;3:20
references: 20959006
references: Anal Quant Cytol Histol. 1989 Jun;11(3):211-7
references: 2472804
references: Cell. 1997 Feb 7;88(3):323-31
references: 9039259
references: Urol Oncol. 2003 Sep-Oct;21(5):334-41
references: 14670539
references: BJU Int. 2013 Aug;112(4):E372-82
references: 23350736
references: Urol Res. 1998;26(4):223-33
references: 9759995
references: PLoS Negl Trop Dis. 2011 Oct;5(10):e1348
references: 22022628
references: Urology. 2006 Mar;67(3 Suppl 1):3-8; discussion 8-10
references: 16530066
references: PLoS Negl Trop Dis. 2012;6(11):e1912
references: 23209855
references: Cancer Genet Cytogenet. 2002 Jan 1;132(1):41-5
references: 11801307
references: Int J Cancer. 1999 Mar 1;80(5):656-61
references: 10048962
references: Histochem Cell Biol. 1999 May;111(5):345-58
references: 10403113
references: Nature. 1997 Sep 18;389(6648):237-8
references: 9305835
references: Cancer. 2009 Jun 25;117(3):167-73
references: 19365828
references: Urology. 2005 Dec;66(6 Suppl 1):35-63
references: 16399415